Raise your hand if you have fibromyalgia. Raise your hand if you're sick of this ruthless condition. If you raised your hand for both questions, you'll want to find out what else we have to say.
Anyone who has to live 24/7 with fibromyalgia knows the depths of this disease and that there's no known cure. Those with fibromyalgia have likely tried everything to relieve that daily pain. Everything — until now.
Something to Chew on
MedChewRx is a new treatment made from actual chewing gum with cannabis. The manufacturers created this directly for the treatment of chronic pain, particularly fibromyalgia.
Photo Courtesy: Medical Health News
According to the company's website, "The patented controlled-release, functional chewing gum is the first preparation of its kind."
Clinical trials are currently underway at the Free University of Amsterdam, The Netherlands, in collaboration with the University of Plymouth, UK, in addition to an academic center in the U.S. for the patented delivery of cannabinoids for the treatment of chronic pain.
Their research etiquette is managed with strict adherence to the FDA/EMA guidelines. AXIM’s study team is the first to employ the benefits of mastication, which is a method of digestion by chewing. By utilizing mastication, you are able to break down enzymes more efficiently while increasing the surface area of the chewable substance. This is basically a fancy way of saying "chew your medicine."
The formula carries equal quantities of Cannabidiol (CBD) and tetrahydrocannabinol (THC) alike, which are the operating ingredients regarding marijuana, remitting 5 mg of each.
Everyone can breathe a sigh of relief because chewing this medication as compared to swallowing a pill means it skips over your liver so that you get relief — faster.
According to Medical Health News, other benefits include:
- Improvement of age-related cognitive decline
- Neuroprotective and neurostimulatory effects on the mind
- Stimulation of the cardiovascular system
- Stress relief
With anything, there are positives as well as negatives. And in reality, nothing is ever perfect.
AXIM Biotech Pharmaceuticals' lead overseer for the clinical trial of this treatment, Professor John Zajicek, revealed, "This is not quite a home run just yet. There have been some side effects reported so far, though it is unclear what those are, and the medicine displays a lack of the 'peak', or a less potent high, associated with traditional forms of cannabis."
At this time, further investigation is necessary in order to prove its effectiveness to treat chronic pain. Safety is, of course, another key factor that the trials are currently deciphering.The end result of their efforts is to be go-to for the everyday chronic pain patient to use on the go for all-day relief.